Generate a tailored SOP for Dr. Jean Villard. Improve your application with a focused, well-structured draft.
Jean Villard is a full professor at the University of Geneva (UNIGE), affiliated with the Translational Research Centre in Oncohaematology. He specializes in internal medicine and immunology, with a focus on hematopoietic stem cell transplantation (HSCT). Villard completed his MD-PhD at UNIGE and has trained at the Geneva University Hospital, as well as completing a postdoctoral fellowship at Massachusetts General Hospital, Harvard Medical School. His research centers on the immunogenetic factors influencing HSCT, particularly the role of HLA and KIR genes in donor selection to prevent relapse and graft-versus-host disease (GVHD). He leads the cellular therapy laboratory at HUG and is involved in various national and international committees, contributing significantly to the field of immunogenetics. His work includes high-resolution typing of HLA loci to improve donor access for HSCT, novel approaches to KIR genotyping, and extensive TCR analysis to identify clinical predictors of GVHD outcomes. Additionally, Villard contributes to the European Federation for Immunogenetics and has established a large patient cohort for clinical studies in this domain.
University of Geneva • Geneva, Switzerland
Leading research in immunogenetics, focusing on HSCT and cellular therapies.
Includes Department of Management, Finance, Economics, and Statistics programs. GMAT is strongly encouraged but not mandatory for most GSEM masters.